Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eRapa in Familial Adenomatous Polyposis
NCT06950385Phase 3Recruiting
- Sponsor
- Emtora Biosciences
- Start
- Jul 2025
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of sirolimus in familial adenomatous polyposis (FAP), sponsored by Emtora Biosciences. Started Jul 2025; status: recruiting.
02
Drugs
sirolimus
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT06950385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06950385.